|
|||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
Intended Use : The Drew DS360 is intended for the measurement of glycated hemoglobin (HbA1c) in blood samples. HbA1c is used to monitor diabetes. The system’s high throughput and automated primary tube sampling, low maintenance, easy to use interface and full color touch screen makes this an ideal addition for the main laboratory, clinic or satellite laboratory settings. Features :
Scientific Principle: The DS360 uses high pressure cation exchange liquid chromatography in conjunction with gradient elution to separate human hemoglobin subtypes and variants from hemolysed whole blood. The unit will accept whole blood or pre-diluted samples before preparing, incubating and analyzing samples automatically. The separated hemoglobin fractions are monitored by means of absorption of light and the chromatogram obtained is recorded and stored by the internal computer. A software program in the instrument performs the analysis of the chromatogram and generates a results report through any attached USB printer. Operation: Sample Preparation : 6µL whole blood per 1ml of Haemolyser or 200uL of whole blood Primary tube sampling. Throughput : 3.5 minutes per sample Reproducibility Determined according to NGSP methodology. A normal and an abnormal patient sample were analyzed in duplicate, twice a day for 20 days, giving a total of 80 replicate analyses for each level. Normal (5.8% HBA1c)
Abnormal (8.3% HBA1c)
Dimensions etc :
Supporting Products :
Carousel set up :
Results :
Example Report :
Brochure : You need Adobe Reader to view or print the brochure. If you do not already have the Reader, then you can download it, free of charge, from Adobe. More details ... Click here to view or print the DS360 brochure
|
||||||||||||||||||||||||||||||||||||||||||||||||||